You could start here
There is research from prior years as well but some of it might be old ('cept the science parts!!)
The hyperlinks should work.
The patents are good, there are some old broker reports which provide super summaries too, I'll include one of my faves here :
https://paradigmbiopharma.com/wp-content/uploads/2022/05/Baker-Young-Research-Report-February-2021-.pdf
Mozz Research 2023
TITLE.....................................................................................DATE PUBLISHED
008 - 12 Month data release Q & A ......................................13/10/23
008 - 56 Day read out ..........................................................04/04/23
008 - The 12 month study ....................................................04/10/23
008 - The Granular link ........................................................15/10/23
008 Update ..........................................................................01/01/23
Accelerated Application Analysis .........................................21/05/23
AGM - 2023 - Part 1 - The Meeting .....................................30/11/23
AGM - 2023 - Part 2 - Q&A .................................................02/12/23
AGM - 2023 - Part 3 - Mozz Reflections .............................02/12/23
Anaesthetist chat ................................................................02/07/23
BML Findings - Part 1 .........................................................22/04/23
BML Findings - Part 2 .........................................................22/04/23
Canine Study ......................................................................08/07/23
Cholesterol and PPS - Part 1 .............................................29/07/23
Cholesterol and PPS - Part 2 .............................................29/07/23
Competitors - a comparison ...............................................11/03/23
Copy me not - Bene's PPS .................................................18/02/23
Corticosteroids and Osteoporosis .......................................07/10/23
Deals and PAR ....................................................................03/09/23
DMOAD Definition - Part 1 ..................................................25/02/23
DMOAD Definition - Part 2 ..................................................25/02/23
Doctor Doctor article ...........................................................22/07/23
Donkeys and iPPS...............................................................09/09/23
Edison - Q&A.......................................................................07/04/23
Extracellular Matrix, MMP and DMOAD..............................29/01/13
HA - My second favourite molecule.....................................28/10/23
Hyaluronic Acid - iPPS's MOA............................................19/02/23
Inflammation - Runaway.....................................................14/01/23
Insurance - high level calc..................................................15/06/23
Kumagai & one of the fantastic fours..................................28/05/23
Load Bearing Properties.....................................................29/04/23
Lysosomal Connection.......................................................13/05/23
Miracle of iPPS (Part 3)......................................................12/06/23
MPS - The miracle of iPPS revisited - Part 1......................11/11/23
MPS - The miracle of iPPS revisited - Part 2......................11/11/23
MPS - What do they really want?.......................................30/09/23
OARSI - Mozz Notes Part 1 - CTS.....................................21/03/23
OARSI - Mozz Notes Part 2 - Intro.....................................23/03/23
OARSI - Mozz Notes Part 3 - The Conference..................25/03/23
OARSI - Mozz Notes Part 4 - Competitor Analysis............04/06/23
Options - a 101..................................................................04/11/23
Osteophytes and iPPS.......................................................23/09/23
P Value Primer...................................................................08/04/23
Patient Interview - Part 1...................................................24/06/23
Patient Interview - Part 2...................................................24/06/23
Patient Interview - Part 3 - The follow up..........................16/09/23
Poor competition...............................................................04/02/23
Promedicus comparison....................................................12/08/23
Pros and Cons after our latest Cash Raising Round.........01/11/23
Reddit - Branching out.......................................................21/10/23
Repair and Regeneration - Part 1.....................................04/03/23
Repair and Regeneration - Part 2.....................................04/03/23
Scene behind the screen..................................................09/05/23
Scientific Paragraph of the year.......................................15/07/23
Separation - Consistent results........................................28/03/23
SMOAD............................................................................11/02/23
Star rating system for upcoming events...........................15/02/23
Take a deep breath ..........................................................19/05/23
Testimony of testimonies...................................................21/02/23
TGA Provisional update....................................................29/08/23
Timetable - Update...........................................................07/09/23
Upcoming events- traffic light system...............................24/08/23
What do you choose?.......................................................07/06/23
You did what with Pentosan? (Part 2)..............................26/08/23
- Forums
- ASX - By Stock
- PAR
- Why Zilosul could be a golden goose!!
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
6.90%
!
31.0¢

Why Zilosul could be a golden goose!!, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $120.7M |
Open | High | Low | Value | Volume |
29.0¢ | 31.0¢ | 28.0¢ | $97.62K | 331.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 74197 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 54675 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 74197 | 0.285 |
17 | 250527 | 0.280 |
6 | 167137 | 0.275 |
7 | 112441 | 0.270 |
4 | 18195 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 54675 | 2 |
0.315 | 68233 | 4 |
0.320 | 152591 | 8 |
0.325 | 127282 | 6 |
0.330 | 11644 | 1 |
Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online